NewsBack to the news
And the award goes to Cerebiome!
Published on 07/09/2021
Frost & Sullivan identifies Lallemand’s Cerebiome® as the world’s most proven psychobiotic, a major differentiator compared to competitors in the psychobiotics space. Download the full report
Frost & Sullivan has identified Cerebiome® by Lallemand Health Solutions as the world’s most proven psychobiotic, a major differentiator compared to competitors in the probiotics for mental health space. Lallemand Health Solutions has earned Frost & Sullivan’s 2021 Product Leadership Award in the European psychobiotics industry, recognizing Cerebiome®’s ability to deliver the best quality, reliability, overall performance, and strong market positioning.
“Frost & Sullivan applies a rigorous analytical process to evaluate multiple nominees for each award category before determining the final award recipient. The process involves a detailed evaluation of best practices criteria across two dimensions for each nominated company. Lallemand Health Solutions excels in many of the criteria in the psychobiotics space”, confirms Arun Ramesh, Research Manager from Frost & Sullivan.
“We are proud that our pioneering and strongly documented psychobiotic Cerebiome® has been awarded by the industry. This confirms the great work done by our talented teams in research, marketing and regulatory affairs. This award gives our clients another argument to use Cerebiome®, the only psychobiotic with validated health claims in Canada and Brazil for its positive impact on mood, stress, and stress-related gut discomfort.” expressed Isabelle Champié, Vice-President, Sales and Marketing at Lallemand Health Solutions.
According to Frost & Sullivan, Lallemand Health Solutions’ innovative ingredient and its various finished formulations stands out.
“Frost & Sullivan observes the company’s commitment to giving back to society is phenomenal, differentiating it from many other firms in the market.”, adds Ramesh.